Amgen cuts price of cholesterol drug by almost 60%, echoing rival's move
Biotech giant Amgen is lowering the price of its cholesterol medicine Repatha by almost 60 percent, following a similar move from its competitor, after both drugs failed to meet sales expectations.
from Top News & Analysis https://ift.tt/2z1oD76
from Top News & Analysis https://ift.tt/2z1oD76
0 Response to "Amgen cuts price of cholesterol drug by almost 60%, echoing rival's move"
Post a Comment